The Honor Foundation (THF) is assisting veterans as they transition by using the power of network building — one cup of coffee at a time. Headquartered in San Diego, California, the foundation ...

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the ...

Organogenesis (ORGO) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of $0.04. This compares to loss of $0.02 per share a year ago. These figures are adjusted ...

Welcome, ladies and gentlemen, to the First Quarter 2025 Earnings Conference Call for Organogenesis Holdings Inc. [Operator Instructions] Please note that this conference call is being recorded ...

Organogenesis Holdings ORGO stock decreased by 43.36% to $3.02. The market value of their outstanding shares is at $383.7 million. As per the press release, Q1 earnings came out yesterday.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Based on the one-year price targets offered by 4 analysts, the average target price for Organogenesis Holdings Inc (NASDAQ:ORGO) is $6.00 with a high estimate of $7.00 and a low estimate of $5.00.